200,000+ products from a single source!
sales@angenechem.com
Home > Other Heterocycles > 33386-08-2
33386-08-2 | Buspirone Hydrochloride
CAS No: 33386-08-2 Catalog No: AG01A3K0 MDL No:MFCD00078569
Product Description
Catalog Number:
AG01A3K0
Chemical Name:
Buspirone Hydrochloride
CAS Number:
33386-08-2
Molecular Formula:
C21H32ClN5O2
Molecular Weight:
421.9641
MDL Number:
MFCD00078569
IUPAC Name:
8-[4-(4-pyrimidin-2-ylpiperazin-1-yl)butyl]-8-azaspiro[4.5]decane-7,9-dione;hydrochloride
InChI:
InChI=1S/C21H31N5O2.ClH/c27-18-16-21(6-1-2-7-21)17-19(28)26(18)11-4-3-10-24-12-14-25(15-13-24)20-22-8-5-9-23-20;/h5,8-9H,1-4,6-7,10-17H2;1H
InChI Key:
RICLFGYGYQXUFH-UHFFFAOYSA-N
SMILES:
O=C1CC2(CCCC2)CC(=O)N1CCCCN1CCN(CC1)c1ncccn1.Cl
EC Number:
251-489-4
UNII:
207LT9J9OC
Properties
Complexity:
529
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
2
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
421.224g/mol
Formal Charge:
0
Heavy Atom Count:
29
Hydrogen Bond Acceptor Count:
6
Hydrogen Bond Donor Count:
1
Isotope Atom Count:
0
Molecular Weight:
421.97g/mol
Monoisotopic Mass:
421.224g/mol
Rotatable Bond Count:
6
Topological Polar Surface Area:
69.6A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
Literature
| Title | Journal |
|---|---|
| Dopamine D3 receptor is necessary for ethanol consumption: an approach with buspirone. | Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20140701 |
| An exploratory study of combination buspirone and melatonin SR in major depressive disorder (MDD): a possible role for neurogenesis in drug discovery. | Journal of psychiatric research 20121201 |
| Intravenous buspirone for the prevention of postoperative nausea and vomiting. | European journal of clinical pharmacology 20121101 |
| The 5-HT1A-receptor agonist flibanserin reduces drug-induced dyskinesia in RGS9-deficient mice. | Journal of neural transmission (Vienna, Austria : 1996) 20121101 |
| Efficacy of buspirone, a fundus-relaxing drug, in patients with functional dyspepsia. | Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 20121101 |
| Performance in anxiety and spatial memory tests following bilateral vestibular loss in the rat and effects of anxiolytic and anxiogenic drugs. | Behavioural brain research 20121101 |
| Probable drug-drug interaction leading to serotonin syndrome in a patient treated with concomitant buspirone and linezolid in the setting of therapeutic hypothermia. | Journal of clinical pharmacy and therapeutics 20121001 |
| The immediate and the delayed effects of buspirone on zebrafish (Danio rerio) in an open field test: a 3-D approach. | Behavioural brain research 20121001 |
| Buspirone blocks the enhancing effect of the anxiogenic drug RS 79948-197 on consolidation of habit memory. | Behavioural brain research 20121001 |
| Anxiolytic effects of yokukansan, a traditional Japanese medicine, via serotonin 5-HT1A receptors on anxiety-related behaviors in rats experienced aversive stress. | Journal of ethnopharmacology 20120928 |
| Serotonergic and dopaminergic mechanisms in graft-induced dyskinesia in a rat model of Parkinson's disease. | Neurobiology of disease 20120901 |
| Evaluation of buspirone for relapse-prevention in adults with cocaine dependence: an efficacy trial conducted in the real world. | Contemporary clinical trials 20120901 |
| Application of a sensitive and specific LC-MS/MS method for determination of chinensinaphthol methyl ether in rat plasma for a bioavailability study. | Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20120815 |
| Two weeks of buspirone protects against posthypoxic ventilatory pauses in the C57BL/6J mouse strain. | Respiratory physiology & neurobiology 20120731 |
| Effect of buspirone, a 5-HT1A receptor agonist, on esophageal motility in healthy volunteers. | Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus 20120701 |
| Traumatic brain injury-induced cognitive and histological deficits are attenuated by delayed and chronic treatment with the 5-HT1A-receptor agonist buspirone. | Journal of neurotrauma 20120701 |
| Evaluation of a combined treatment paradigm consisting of environmental enrichment and the 5-HT1A receptor agonist buspirone after experimental traumatic brain injury. | Journal of neurotrauma 20120701 |
| Decision time and perseveration of adolescent rats in the T-maze are affected differentially by buspirone and independent of 5-HT-1A expression. | Pharmacology, biochemistry, and behavior 20120701 |
| A semi-automated method for the integrated evaluation of half-life and metabolic soft spots of discovery compounds. | Bioanalysis 20120701 |
| Buspirone: what is it all about? | Brain research 20120621 |
| Mechanism-based pharmacokinetic/pharmacodynamic modeling of rat prefrontal cortical dopamine response to dual acting norepinephrine reuptake inhibitor and 5-HT1A partial agonist. | The AAPS journal 20120601 |
| Determinants of effective cooling during endovascular hypothermia. | Neurocritical care 20120601 |
| Reversal of cocaine withdrawal-induced anxiety by ondansetron, buspirone and propranolol. | Behavioural brain research 20120516 |
| Functional and physiological effects of treadmill training induced by buspirone, carbidopa, and L-DOPA in clenbuterol-treated paraplegic mice. | Neurorehabilitation and neural repair 20120501 |
| Outcomes on the pharmacopsychometric triangle in bupropion-SR vs. buspirone augmentation of citalopram in the STAR*D trial. | Acta psychiatrica Scandinavica 20120401 |
| An 8-week, randomized controlled trial of atomoxetine, atomoxetine plus buspirone, or placebo in adults with ADHD. | The Journal of clinical psychiatry 20120401 |
| Synthesis, in vitro binding studies and docking of long-chain arylpiperazine nitroquipazine analogues, as potential serotonin transporter inhibitors. | European journal of medicinal chemistry 20120301 |
| Use of buspirone and fluoxetine for breathing problems in Rett syndrome. | Pediatric neurology 20120301 |
| Treating depression after initial treatment failure: directly comparing switch and augmenting strategies in STAR*D. | Journal of clinical psychopharmacology 20120201 |
| Paroxetine-induced severe sleep bruxism successfully treated with buspirone. | Clinics (Sao Paulo, Brazil) 20120201 |
| Quantitative analysis of atractylenolide I in rat plasma by LC-MS/MS method and its application to pharmacokinetic study. | Journal of pharmaceutical and biomedical analysis 20120125 |
| Menstrual cycle-dependent febrile episode mediated by sequence-specific repression of poly(ADP-ribose) polymerase-1 on the transcription of the human serotonin receptor 1A gene. | Human mutation 20120101 |
| An efficient synthesis of aripiprazole, buspirone and NAN-190 by the reductive alkylation of amines procedure. | Archiv der Pharmazie 20120101 |
| Interventions for treating anxiety after stroke. | The Cochrane database of systematic reviews 20111207 |
| Interaction of estrogen with central serotonergic mechanisms in human sensory processing: loudness dependence of the auditory evoked potential and mismatch negativity. | Journal of psychopharmacology (Oxford, England) 20111201 |
| Buspirone for bruxism in a child with pervasive developmental disorder-not otherwise specified. | Journal of child and adolescent psychopharmacology 20111201 |
| Quantitative estimation of circulating metabolites without synthetic standards by ultra-high-performance liquid chromatography/high resolution accurate mass spectrometry in combination with UV correction. | Rapid communications in mass spectrometry : RCM 20111115 |
| Does the presence of accompanying symptom clusters differentiate the comparative effectiveness of second-line medication strategies for treating depression? | Depression and anxiety 20111101 |
| Pharmacological treatment of generalized anxiety disorder. | Expert opinion on pharmacotherapy 20111101 |
| Buspirone before prenatal stress protects against adverse effects of stress on emotional and inflammatory pain-related behaviors in infant rats: age and sex differences. | Brain research 20111024 |
| A pilot study of the efficacy and safety of paroxetine augmented with risperidone, valproate, buspirone, trazodone, or thyroid hormone in adult Chinese patients with treatment-resistant major depression. | Journal of clinical psychopharmacology 20111001 |
| Attenuation of apomorphine-induced sensitization by buspirone. | Pharmacology, biochemistry, and behavior 20110901 |
| Effects of anxiolytics in zebrafish: similarities and differences between benzodiazepines, buspirone and ethanol. | Pharmacology, biochemistry, and behavior 20110901 |
| Buspirone, fexofenadine, and omeprazole: quantification of probe drugs and their metabolites in human plasma. | Journal of pharmaceutical and biomedical analysis 20110715 |
| Phasic and sustained fear are pharmacologically dissociable in rats. | Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20110701 |
| The effect of component of microemulsions on transdermal delivery of buspirone hydrochloride. | Journal of pharmaceutical sciences 20110601 |
| [Serotonin receptor 1A-modulated dephosphorylation of glycine receptor α3: a new molecular mechanism of breathing control for compensation of opioid-induced respiratory depression without loss of analgesia]. | Schmerz (Berlin, Germany) 20110601 |
| Drug therapies for tardive dyskinesia: Part 1. | Journal of psychosocial nursing and mental health services 20110601 |
| Increased plasma corticosterone levels after periaqueductal gray stimulation-induced escape reaction or panic attacks in rats. | Behavioural brain research 20110415 |
| Development and evaluation of a multiple-plate fraction collector for sample processing: application to radioprofiling in drug metabolism studies. | Journal of pharmaceutical and biomedical analysis 20110405 |
| Agonists at the serotonin receptor (5-HT(1A)) protect the retina from severe photo-oxidative stress. | Investigative ophthalmology & visual science 20110404 |
| Study of potential inhibitors of thyroid iodide uptake by using CHO cells stably expressing the human sodium/iodide symporter (hNIS) protein. | Journal of endocrinological investigation 20110301 |
| Maternal buspirone protects against the adverse effects of in utero stress on emotional and pain-related behaviors in offspring. | Physiology & behavior 20110201 |
| Application of a fluorescence-based continuous-flow bioassay to screen for diversity of cytochrome P450 BM3 mutant libraries. | Journal of biomolecular screening 20110201 |
| [Effects of chronic buspirone treatment on female mice exposed to the long-lasting psychoemotional influence]. | Rossiiskii fiziologicheskii zhurnal imeni I.M. Sechenova 20110201 |
| The mGluR5 antagonist 2-methyl-6-(phenylethynyl)-pyridine (MPEP) potentiates conditioned place preference induced by various addictive and non-addictive drugs in rats. | Addiction biology 20110101 |
| Anxiolytic and anxiogenic drug effects on male and female gerbils in the black-white box. | Behavioural brain research 20110101 |
| Density and function of central serotonin (5-HT) transporters, 5-HT1A and 5-HT2A receptors, and effects of their targeting on BTBR T+tf/J mouse social behavior. | Journal of neurochemistry 20110101 |
| Pharmacological treatment of cannabis dependence. | Current pharmaceutical design 20110101 |
| Zebrafish assessment of cognitive improvement and anxiolysis: filling the gap between in vitro and rodent models for drug development. | Reviews in the neurosciences 20110101 |
| Duloxetine-induced nocturnal bruxism resolved by buspirone: case report. | Clinical neuropharmacology 20110101 |
| Buspirone improves the anti-cataleptic effect of levodopa in 6-hydroxydopamine-lesioned rats. | Pharmacological reports : PR 20110101 |
| Generalised anxiety disorder. | BMJ clinical evidence 20110101 |
| Hydroxyzine for generalised anxiety disorder. | The Cochrane database of systematic reviews 20101208 |
| Formulation and optimization of solid lipid nanoparticles of buspirone HCl for enhancement of its oral bioavailability. | Journal of liposome research 20101201 |
| Buspirone versus methylphenidate in the treatment of attention deficit hyperactivity disorder: a double-blind and randomized trial. | Child psychiatry and human development 20101201 |
| Evaluation of central serotonin sensitivity in breast cancer survivors with cancer-related fatigue syndrome. | Journal of pain and symptom management 20101201 |
| Attenuation of fear-like response by escitalopram treatment after electrical stimulation of the midbrain dorsolateral periaqueductal gray. | Experimental neurology 20101201 |
| A double-blind, randomized, and placebo-controlled trial of buspirone added to risperidone in patients with chronic schizophrenia. | Journal of clinical psychopharmacology 20101201 |
| Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis. | Bioorganic & medicinal chemistry letters 20101101 |
| Graft-induced dyskinesias in Parkinson's disease: what is it all about? | Cell stem cell 20100806 |
| Agonist-dependent modulation of G-protein coupling and transduction of 5-HT1A receptors in rat dorsal raphe nucleus. | The international journal of neuropsychopharmacology 20100801 |
| Chronic buspirone treatment decreases 5-HT1B receptor densities and the serotonin transporter but increases the density of 5-HT2A receptors in the bulbectomized rat model of depression: an autoradiographic study. | Brain research 20100723 |
| Dose-effect study of Gelsemium sempervirens in high dilutions on anxiety-related responses in mice. | Psychopharmacology 20100701 |
| The pharmacologic treatment of anxiety disorders: a review of progress. | The Journal of clinical psychiatry 20100701 |
| Effect of acute and chronic buspirone administration on communicativeness of mice with experience of defeats in social conflicts. | Bulletin of experimental biology and medicine 20100701 |
| Enhanced bioavailability of buspirone from reservoir-based transdermal therapeutic system, optimization of formulation employing Box-Behnken statistical design. | AAPS PharmSciTech 20100601 |
| Hormonal responses to the 5-HT1A agonist buspirone in remitted endogenous depressive patients after long-term imipramine treatment. | Psychoneuroendocrinology 20100501 |
| Buspirone-induced changes in the serotonergic and non-serotonergic cells in the dorsal raphe nucleus of rats. | Neuroscience letters 20100405 |
| Venlafaxine-associated nocturnal bruxism in a depressive patient successfully treated with buspirone. | Journal of psychopharmacology (Oxford, England) 20100401 |
| Randomized, single-blind, trial of sertraline and buspirone for treatment of elderly patients with generalized anxiety disorder. | Psychiatry and clinical neurosciences 20100401 |
| Oral administration of a tri-therapy for central pattern generator activation in paraplegic mice: proof-of-concept of efficacy. | Biotechnology journal 20100401 |
| Buspirone attenuates tolerance to analgesic effect of morphine in mice with skin cancer. | Pakistan journal of pharmaceutical sciences 20100401 |
| [Effects of prenatal influences of buspirone and stress on indices of inflammatory pain response and depressive behaviour in adult rats]. | Rossiiskii fiziologicheskii zhurnal imeni I.M. Sechenova 20100401 |
| Oxidative stress in rat hippocampus caused by pilocarpine-induced seizures is reversed by buspirone. | Brain research bulletin 20100316 |
| Buspirone transdermal administration for menopausal syndromes, in vitro and in animal model studies. | International journal of pharmaceutics 20100315 |
| 5HT1A-mediated stimulation of cortisol release in major depression: use of non-invasive cortisol measurements to predict clinical response. | European archives of psychiatry and clinical neuroscience 20100301 |
| Effect of serotonergic system on AVP secretion induced by physical exercise. | Neuropeptides 20100201 |
| The alarm pheromone in male rats as a unique anxiety model: psychopharmacological evidence using anxiolytics. | Pharmacology, biochemistry, and behavior 20100201 |
| Mouse models of apnea: strain differences in apnea expression and its pharmacologic and genetic modification. | Advances in experimental medicine and biology 20100101 |
| Differential involvement of 5-HT(1A) and 5-HT(1B/1D) receptors in human interferon-alpha-induced immobility in the mouse forced swimming test. | Arzneimittel-Forschung 20100101 |
| Buspirone improves 6-hydroxydopamine-induced catalepsy through stimulation of nigral 5-HT(1A) receptors in rats. | Pharmacological reports : PR 20100101 |
| PRX-00023, a selective serotonin 1A receptor agonist, reduces ultrasonic vocalizations in infant rats bred for high infantile anxiety. | Pharmacology, biochemistry, and behavior 20091101 |
| Buspirone, chlordiazepoxide and diazepam effects in a zebrafish model of anxiety. | Pharmacology, biochemistry, and behavior 20091101 |
| A placebo-controlled trial of buspirone for the treatment of marijuana dependence. | Drug and alcohol dependence 20091101 |
| Pharmacogenetics studies in STAR*D: strengths, limitations, and results. | Psychiatric services (Washington, D.C.) 20091101 |
| The effects of buspirone and diazepam on aversive context- and social isolation-induced ultrasonic vocalisation. | Physiology & behavior 20091019 |
| Genetic mapping of targets mediating differential chemical phenotypes in Plasmodium falciparum. | Nature chemical biology 20091001 |
| Serotonin targets inhibitory synapses to induce modulation of network functions. | Philosophical transactions of the Royal Society of London. Series B, Biological sciences 20090912 |
| Two-injection workflow for a liquid chromatography/LTQ-Orbitrap system to complete in vivo biotransformation characterization: demonstration with buspirone metabolite identification. | Rapid communications in mass spectrometry : RCM 20090901 |
| Development of high performance liquid chromatography method for buspirone in rabbit serum: Application to pharmacokinetic study. | Analytica chimica acta 20090811 |
| Treatment of cognitive dysfunction in chronic schizophrenia by augmentation of atypical antipsychotics with buspirone, a partial 5-HT(1A) receptor agonist. | Human psychopharmacology 20090801 |
| Carboxy group derivatization for enhanced electron-transfer dissociation mass spectrometric analysis of phosphopeptides. | Proteomics 20090801 |
| The sigma-1 antagonist BMY-14802 inhibits L-DOPA-induced abnormal involuntary movements by a WAY-100635-sensitive mechanism. | Psychopharmacology 20090701 |
| Suppression of shivering during hypothermia using a novel drug combination in healthy volunteers. | Anesthesiology 20090701 |
| The partial 5-HT1A receptor agonist buspirone enhances neurogenesis in the opossum (Monodelphis domestica). | European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 20090601 |
| Anxiolytic-like effects of ginsenosides Rg3 and Rh2 from red ginseng in the elevated plus-maze model. | Planta medica 20090601 |
| Proposal of buspirone collision-induced dissociation rearrangement by exact mass measurements. | Rapid communications in mass spectrometry : RCM 20090601 |
| Spectroscopic study of the reaction mechanism of buspirone interaction with iodine and tetracyanoethylene reagents and its applications. | Drug testing and analysis 20090601 |
| Anxiolytics antagonize yohimbine-induced central noradrenergic activity: a concomitant in vivo voltammetry-electrophysiology model of anxiety. | Journal of neuroscience methods 20090530 |
| What predicts attrition in second step medication treatments for depression?: a STAR*D Report. | The international journal of neuropsychopharmacology 20090501 |
| Ice-cold saline for the induction of mild hypothermia in patients with acute ischemic stroke: a pilot study. | Stroke 20090501 |
| Brain targeting studies on buspirone hydrochloride after intranasal administration of mucoadhesive formulation in rats. | The Journal of pharmacy and pharmacology 20090501 |
| The effect of oral buspirone, pyridostigmine, and bethanechol on esophageal function evaluated with combined multichannel esophageal impedance-manometry in healthy volunteers. | Journal of clinical gastroenterology 20090301 |
| Sensitization, duration, and pharmacological blockade of anxiety-like behavior following repeated ethanol withdrawal in adolescent and adult rats. | Alcoholism, clinical and experimental research 20090301 |
| Synthesis and pharmacological evaluation of aminopyrimidine series of 5-HT1A partial agonists. | Bioorganic & medicinal chemistry letters 20090215 |
| Porcine buccal mucosa as an in vitro model: relative contribution of epithelium and connective tissue as permeability barriers. | Journal of pharmaceutical sciences 20090201 |
| Prevalence of ergot derivatives in natural ryegrass pastures: detection and pathogenicity in the horse. | Theriogenology 20090201 |
| Preliminary evidence of safety following administration of L-DOPA and buspirone in an incomplete monoplegic patient. | Spinal cord 20090101 |
| 5-HT(1A) receptors in the frontal cortical brain areas in Cloninger type 1 and 2 alcoholics measured by whole-hemisphere autoradiography. | Alcohol and alcoholism (Oxford, Oxfordshire) 20090101 |
| Both acute and chronic buspirone treatments have different effects on regional 5-HT synthesis in Flinders Sensitive Line rats (a rat model of depression) than in control rats. | Neurochemistry international 20090101 |
| Augmentation strategies for treatment-resistant depression. | Current opinion in psychiatry 20090101 |
| Combined neuroprotective modalities coupled with thrombolysis in acute ischemic stroke: a pilot study of caffeinol and mild hypothermia. | Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association 20090101 |
| Refractory generalized anxiety disorder. | The Journal of clinical psychiatry 20090101 |
| Effect of buspirone on thermal sensory and pain thresholds in human volunteers. | BMC clinical pharmacology 20090101 |
| Reduction of the number of new cells reaching olfactory bulbs impairs olfactory perception in the adult opossum. | Acta neurobiologiae experimentalis 20090101 |
| Low-dose buspirone, melatonin and low-dose bupropion added to mood stabilizers for severe treatment-resistant bipolar depression. | Psychotherapy and psychosomatics 20090101 |
| Fluoxetine-induced sleep bruxism in an adolescent treated with buspirone: a case report. | Special care in dentistry : official publication of the American Association of Hospital Dentists, the Academy of Dentistry for the Handicapped, and the American Society for Geriatric Dentistry 20090101 |
| Interaction between serotonin 5-HT1A receptors and beta-endorphins modulates antidepressant response. | Progress in neuro-psychopharmacology & biological psychiatry 20081212 |
| Influence of buspirone on gastric sensorimotor function in man. | Alimentary pharmacology & therapeutics 20081201 |
| Anxiolytic activity of a phytochemically characterized Passiflora incarnata extract is mediated via the GABAergic system. | Planta medica 20081201 |
| Modulation of buspirone HCl release from hypromellose matrices using chitosan succinate: implications for pH-independent release. | European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V 20081101 |
| The molecular interactions of buspirone analogues with the serotonin transporter. | Bioorganic & medicinal chemistry 20081015 |
| Serotonin1A receptors in the pathophysiology of schizophrenia: development of novel cognition-enhancing therapeutics. | Advances in therapy 20081001 |
| Dose-dependent response of central dopaminergic systems to buspirone in mice. | Indian journal of experimental biology 20081001 |
| Can in vitro metabolism-dependent covalent binding data in liver microsomes distinguish hepatotoxic from nonhepatotoxic drugs? An analysis of 18 drugs with consideration of intrinsic clearance and daily dose. | Chemical research in toxicology 20080901 |
| The efficacy of combined estrogen and buspirone treatment in olivopontocerebellar atrophy. | Journal of the neurological sciences 20080815 |
| Effects of buspirone on posthypoxic ventilatory behavior in the C57BL/6J and A/J mouse strains. | Journal of applied physiology (Bethesda, Md. : 1985) 20080801 |
| Post-sigh breathing behavior and spontaneous pauses in the C57BL/6J (B6) mouse. | Respiratory physiology & neurobiology 20080731 |
| Buspirone induced acute and chronic changes of neural activation in the periaqueductal gray of rats. | Neuroscience 20080731 |
| Evidence of an enhanced central 5HT response in irritable bowel syndrome and in the rat maternal separation model. | Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society 20080601 |
| Sustained-release of buspirone HCl by co spray-drying with aqueous polymeric dispersions. | European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V 20080601 |
| In vitro assessment of mitochondrial dysfunction and cytotoxicity of nefazodone, trazodone, and buspirone. | Toxicological sciences : an official journal of the Society of Toxicology 20080601 |
| Apneusis responding to buspirone in multiple sclerosis. | Multiple sclerosis (Houndmills, Basingstoke, England) 20080601 |
| Validating an Ataxia Functional Composite Scale in spinocerebellar ataxia. | Journal of the neurological sciences 20080515 |
| Buspirone and serotonin in spinocerebellar ataxia. | Journal of the neurological sciences 20080515 |
| Effects of fluoxetine on hippocampal rhythmic slow activity and behavioural inhibition. | Behavioural pharmacology 20080501 |
| How multiple medication use evolves and the importance of therapeutic trials: the slippery slide. | Journal of psychiatric practice 20080501 |
| Intranasal mucoadhesive buspirone formulation: in vitro characterization and nasal clearance studies. | Die Pharmazie 20080501 |
| Chronic buspirone treatment normalizes open field behavior in olfactory bulbectomized rats: assessment with a quantitative autoradiographic evaluation of the 5-HT1A binding sites. | Brain research bulletin 20080328 |
| Treating body dysmorphic disorder with medication: evidence, misconceptions, and a suggested approach. | Body image 20080301 |
| Pharmacotherapy and psychotherapy in cannabis withdrawal and dependence. | Expert review of neurotherapeutics 20080301 |
| The stimulus effects of 8-OH-DPAT: evidence for a 5-HT2A receptor-mediated component. | Pharmacology, biochemistry, and behavior 20080101 |
| Comparison of the effects of deramciclane, ritanserin and buspirone on extracellular dopamine and its metabolites in striatum and nucleus accumbens of freely moving rats. | Basic & clinical pharmacology & toxicology 20080101 |
| Buspirone for autistic disorder in a woman with an intellectual disability. | The Annals of pharmacotherapy 20080101 |
| Effects of midazolam and buspirone on in vivo concentration of amino acids and monoamine metabolites in the rat hippocampus. | Pharmacological reports : PR 20080101 |
| Effect of buspirone on the behavioral regulation of rats in low versus high anxiety conditions. | Arzneimittel-Forschung 20080101 |
| Marijuana neurobiology and treatment. | Substance abuse 20080101 |
| Rapid and sensitive characterization of the metabolite formation enzyme kinetics of radiolabeled drugs using stop-flow liquid radiochromatography. | Drug metabolism letters 20080101 |
| Tolerance in the anxiolytic profile following repeated administration of diazepam but not buspirone is associated with a decrease in the responsiveness of postsynaptic 5-HT-1A receptors. | Acta biologica Hungarica 20071201 |
| Allometric scaling of pharmacodynamic responses: application to 5-Ht1A receptor mediated responses from rat to man. | Pharmaceutical research 20071101 |
| Repeated cortisol administration attenuates the EEG response to buspirone in healthy volunteers: evidence for desensitization of the 5-HT1A autoreceptor. | Journal of psychopharmacology (Oxford, England) 20071101 |
| Behavioral response to emotional stress in rabbits: role of serotonin and serotonin2A receptors. | Behavioural pharmacology 20071101 |
| [Pharmacological therapy for therapy-resistant depression. New developments]. | Der Nervenarzt 20071101 |
| Response surface analysis of solution-mediated polymorphic transformation of buspirone hydrochloride. | Journal of pharmaceutical and biomedical analysis 20071018 |
| Defensive-like behaviors induced by ultrasound: further pharmacological characterization in Lister-hooded rats. | Psychopharmacology 20071001 |
| Dose related effects of buspirone on serum electrolyte balance, plasma osmolality and systolic blood pressure (SBP) in rats. | Pakistan journal of pharmaceutical sciences 20071001 |
| Pharmacokinetics of 6-hydroxybuspirone and its enantiomers administered individually or following buspirone administration in humans. | Biopharmaceutics & drug disposition 20071001 |
| alpha1-Adrenoceptors in proximal segments of tail arteries from control and reserpinised rats. | Naunyn-Schmiedeberg's archives of pharmacology 20071001 |
| Augmentation strategies for treatment-resistant depression: a literature review. | Journal of clinical pharmacy and therapeutics 20071001 |
| The efficacy of the combination of sertraline with buspirone for smoking cessation. A randomized clinical trial in nondepressed smokers. | European archives of psychiatry and clinical neuroscience 20071001 |
| Treatment of spinocerebellar ataxia with buspirone. | Journal of the neurological sciences 20070915 |
| Drug challenges reveal differences in mediation of stress facilitation of voluntary alcohol drinking and withdrawal-induced anxiety in alcohol-preferring P rats. | Alcoholism, clinical and experimental research 20070901 |
| Effect of buspirone, a serotonin1A partial agonist, on cognitive function in schizophrenia: a randomized, double-blind, placebo-controlled study. | Schizophrenia research 20070901 |
| 6-Hydroxybuspirone is a major active metabolite of buspirone: assessment of pharmacokinetics and 5-hydroxytryptamine1A receptor occupancy in rats. | Drug metabolism and disposition: the biological fate of chemicals 20070801 |
| Hormonal response to buspirone is not impaired in major depression. | Human psychopharmacology 20070801 |
| Simultaneous determination of metabolic stability and identification of buspirone metabolites using multiple column fast liquid chromatography time-of-flight mass spectrometry. | Journal of chromatography. A 20070713 |
| Solubility analysis of buspirone hydrochloride polymorphs: measurements and prediction. | International journal of pharmaceutics 20070629 |
| Mass spectrometric investigation of buspirone drug in comparison with thermal analyses and MO-calculations. | Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy 20070601 |
| Unintentional onset of anorexia nervosa. | Eating and weight disorders : EWD 20070601 |
| Effects of cytochrome P450 (CYP) 3A4 inhibitors on the anxiolytic action of tandospirone in rat contextual conditioned fear. | Progress in neuro-psychopharmacology & biological psychiatry 20070509 |
| Effects of citalopram treatment on hypothermic and hormonal responses to the 5-HT1A receptor agonist buspirone in patients with major depression and therapeutic response. | Psychoneuroendocrinology 20070501 |
| Cognitive therapy versus medication in augmentation and switch strategies as second-step treatments: a STAR*D report. | The American journal of psychiatry 20070501 |
| Reversal of haloperidol-induced tardive vacuous chewing movements and supersensitive somatodendritic serotonergic response by buspirone in rats. | Pharmacology, biochemistry, and behavior 20070501 |
| Mania in a case of polypsychopharmacology: pharmacodynamic and pharmacokinetic considerations. Do you believe in magic? | Journal of psychiatric practice 20070501 |
| Effects of buspirone on the immediate positive and delayed negative properties of intravenous cocaine as measured in the conditioned place preference test. | Pharmacology, biochemistry, and behavior 20070501 |
| Anti-anxiety effects of Apocynum venetum L. in the elevated plus maze test. | Journal of ethnopharmacology 20070404 |
| Quantitative and molecular analysis of buspirone hydrochloride polymorphs. | Journal of pharmaceutical sciences 20070301 |
| Lack of deleterious effects of buspirone on cognition in healthy male volunteers. | Journal of psychopharmacology (Oxford, England) 20070301 |
| Reversal of haloperidol-induced extrapyramidal symptoms by buspirone: a time-related study. | Behavioural pharmacology 20070301 |
| Screening of 5-HT1A receptor antagonists using molecularly imprinted polymers. | Journal of the American Chemical Society 20070214 |
| Modulation of fear-potentiated startle and vocalizations in juvenile rhesus monkeys by morphine, diazepam, and buspirone. | Biological psychiatry 20070201 |
| The effect of buspirone on normal and hypoarousal-driven abnormal aggression in rats. | Progress in neuro-psychopharmacology & biological psychiatry 20070130 |
| The partial 5-hydroxytryptamine1A receptor agonist buspirone does not antagonize morphine-induced respiratory depression in humans. | Clinical pharmacology and therapeutics 20070101 |
| Treating inhalant abuse with buspirone. | The American journal on addictions 20070101 |
| The partial 5-HT(1A) agonist buspirone reduces the expression and development of l-DOPA-induced dyskinesia in rats and improves l-DOPA efficacy. | Pharmacology, biochemistry, and behavior 20070101 |
| The combination of buspirone and bupropion in the treatment of depression. | Psychotherapy and psychosomatics 20070101 |
| Flow injection analysis with tubular membrane ion-selective electrode and coated wires for buspirone hydrochloride. | Annali di chimica 20070101 |
| Augmentation strategies to increase antidepressant efficacy. | The Journal of clinical psychiatry 20070101 |
| Effects of buspirone on dopamine dependent behaviours in rats. | Indian journal of physiology and pharmacology 20070101 |
| Anxiolytic activity of a novel potent serotonin 5-HT2C receptor antagonist FR260010: a comparison with diazepam and buspirone. | European journal of pharmacology 20061228 |
| Assay principle for modulators of protein-protein interactions and its application to non-ATP-competitive ligands targeting protein kinase A. | Analytical chemistry 20061215 |
| Quantification of a cytochrome P450 3A4 substrate, buspirone, in human plasma by liquid chromatography-tandem mass spectrometry. | Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20061205 |
| Strategies for managing antidepressant-induced sexual dysfunction: a review. | Current psychiatry reports 20061201 |
| Use of a serotonin 1A receptor agonist to treat restless legs syndrome. | Journal of clinical psychopharmacology 20061201 |
| Anxiolytic effects of the aqueous extract of Uncaria rhynchophylla. | Journal of ethnopharmacology 20061124 |
| Involvement of 5-hydroxytryptamine1A receptors in Delta9-tetrahydrocannabinol-induced catalepsy-like immobilization in mice. | European journal of pharmacology 20061121 |
| Effects of genetic background and null mutation of 5-HT1A receptors on basal and stress-induced body temperature: modulation by serotonergic and GABAA-ergic drugs. | European journal of pharmacology 20061121 |
| Pharmacokinetics of a newly identified active metabolite of buspirone after administration of buspirone over its therapeutic dose range. | Journal of clinical pharmacology 20061101 |
| An increased hypothermic response to buspirone in patients with major depression. | Psychopharmacology 20061001 |
| Anxiolytic-like actions of buspirone in a runway model of intravenous cocaine self-administration. | Pharmacology, biochemistry, and behavior 20061001 |
| 5-HT-1A receptor responsiveness following subchronic administration of buspirone. | Pakistan journal of pharmaceutical sciences 20061001 |
| Rapid desensitization of somatodendritic 5-HT1A receptors by chronic administration of the high-efficacy 5-HT1A agonist, F13714: a microdialysis study in the rat. | British journal of pharmacology 20060901 |
| Thermal effects of whole head submersion in cold water on nonshivering humans. | Journal of applied physiology (Bethesda, Md. : 1985) 20060801 |
| Antidepressant-induced bruxism: need for buspirone? | The international journal of neuropsychopharmacology 20060801 |
| Azapirones for generalized anxiety disorder. | The Cochrane database of systematic reviews 20060719 |
| Therapeutic options: Addressing the current dilemma. | European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 20060701 |
| Reduction in repeated ethanol-withdrawal-induced anxiety-like behavior by site-selective injections of 5-HT1A and 5-HT2C ligands. | Psychopharmacology 20060701 |
| Depression--augmentation or switch after initial SSRI treatment. | The New England journal of medicine 20060615 |
| Enantioselective alpha-hydroxylation of 2-arylacetic acid derivatives and buspirone catalyzed by engineered cytochrome P450 BM-3. | Journal of the American Chemical Society 20060510 |
| Microsphere-based protease assays and screening application for lethal factor and factor Xa. | Cytometry. Part A : the journal of the International Society for Analytical Cytology 20060501 |
| Pharmacokinetics of buspirone in autistic children. | Journal of clinical pharmacology 20060501 |
| Solid-state characterization of buspirone hydrochloride polymorphs. | Pharmaceutical research 20060501 |
| Estrogen prevents 5-HT1A receptor-induced disruptions of prepulse inhibition in healthy women. | Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20060401 |
| Inhibition of hepatobiliary transport as a predictive method for clinical hepatotoxicity of nefazodone. | Toxicological sciences : an official journal of the Society of Toxicology 20060401 |
| Chronic buspirone treatment normalizes regional serotonin synthesis in the olfactory bulbectomized rat brain: an autoradiographic study. | Brain research bulletin 20060331 |
| Pharmacological evaluation of the stress-induced social avoidance model of anxiety. | Brain research bulletin 20060331 |
| Potential vascular alpha1-adrenoceptor blocking properties of an array of 5-HT receptor ligands in the rat. | European journal of pharmacology 20060327 |
| Medication augmentation after the failure of SSRIs for depression. | The New England journal of medicine 20060323 |
| Anxiolytic-like activity of agomelatine and melatonin in three animal models of anxiety. | Behavioural pharmacology 20060201 |
| Automated software-guided identification of new buspirone metabolites using capillary LC coupled to ion trap and TOF mass spectrometry. | Journal of mass spectrometry : JMS 20060201 |
| [Review of neurobehavioral effects of alcohol-related neurodevelopmental disorder in an animal model]. | Nihon Arukoru Yakubutsu Igakkai zasshi = Japanese journal of alcohol studies & drug dependence 20060201 |
| Effect of modulation of serotonergic, cholinergic, and nitrergic pathways on murine fundic size and compliance measured by ultrasonomicrometry. | American journal of physiology. Gastrointestinal and liver physiology 20060101 |
| Immediate-early gene expression in the central nucleus of the amygdala is not specific for anxiolytic or anxiogenic drugs. | Neuropharmacology 20060101 |
| Effects of fluoxetine and buspirone on the panicolytic-like response induced by the activation of 5-HT1A and 5-HT2A receptors in the rat dorsal periaqueductal gray. | Psychopharmacology 20060101 |
| Anti-conflict effects of benzodiazepines in rhesus monkeys: relationship with therapeutic doses in humans and role of GABAA receptors. | Psychopharmacology 20060101 |
| Combined treatment with citalopram and buspirone: effects on serotonin 5-HT2A and 5-HT2C receptors in the rat brain. | Pharmacopsychiatry 20060101 |
| Hyper-anxiety in early sobriety: psychopharmacological treatment strategies. | Journal of psychosocial nursing and mental health services 20060101 |
| Rapid and highly sensitive liquid chromatography/electrospray ionization tandem mass spectrometry method for the quantitation of buspirone in human plasma: application to a pharmacokinetic study. | Rapid communications in mass spectrometry : RCM 20060101 |
| Buspirone for stereotypic movements in elderly with cognitive impairment. | The Journal of neuropsychiatry and clinical neurosciences 20060101 |
| [Efficacy of buspirone and fluoxetine in short-term treatment of bulimia nervosa]. | Psychiatria polska 20060101 |
| Challenging the serotonergic system in Parkinson disease patients: effects on cognition, mood, and motor performance. | Clinical neuropharmacology 20060101 |
| Buspirone for treatment of marijuana dependence: a pilot study. | The American journal on addictions 20060101 |
| [Neonatal buspirone modulates the intermale aggression in adult mice]. | Zhurnal vysshei nervnoi deiatelnosti imeni I P Pavlova 20060101 |
| Inhibition of restraint-induced neuroendocrine and serotonergic responses by buspirone in rats. | Pharmacological reports : PR 20060101 |
| Psychiatric treatment for extremely traumatized civil war refugees from former Yugoslavia. Possibilities and limitations of integrating psychotherapy and medication. | Torture : quarterly journal on rehabilitation of torture victims and prevention of torture 20060101 |
| Buspirone attenuates conditioned fear-induced c-Fos expression in the rat hippocampus. | Neuroscience letters 20051202 |
| Role of sex and sex steroids in mediating pituitary-adrenal responses to acute buspirone treatment in sheep. | Journal of neuroendocrinology 20051201 |
| Motor effects of buspirone: Relationship with dopamine and serotonin in the striatum. | Journal of the College of Physicians and Surgeons--Pakistan : JCPSP 20051201 |
| Attenuation of restraint induced behavioral deficits by buspirone and propranolol in rats. | Journal of the College of Physicians and Surgeons--Pakistan : JCPSP 20051201 |
| Generalised anxiety disorder. | Clinical evidence 20051201 |
| Chronic imipramine treatment sensitizes 5-HT1A and 5-HT 2 A receptors in the dorsal periaqueductal gray matter: evidence from the elevated T-maze test of anxiety. | Behavioural pharmacology 20051101 |
| The use of sleep measures to compare a new 5HT1A agonist with buspirone in humans. | Journal of psychopharmacology (Oxford, England) 20051101 |
| Co-administration of fluoxetine and WAY100635 improves short-term memory function. | European journal of pharmacology 20051017 |
| The 5-HT1A receptor and the stimulus effects of LSD in the rat. | Psychopharmacology 20051001 |
| Prior multiple ethanol withdrawals enhance stress-induced anxiety-like behavior: inhibition by CRF1- and benzodiazepine-receptor antagonists and a 5-HT1a-receptor agonist. | Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20050901 |
| Analysis of low level radioactive metabolites in biological fluids using high-performance liquid chromatography with microplate scintillation counting: method validation and application. | Journal of pharmaceutical and biomedical analysis 20050901 |
| Buspirone in Rett syndrome respiratory dysfunction. | Brain & development 20050901 |
| Efficacy of the 5-HT1A agonist, buspirone hydrochloride, in migraineurs with anxiety: a randomized, prospective, parallel group, double-blind, placebo-controlled study. | Headache 20050901 |
| Use of buspirone and enrichment to manage aberrant behavior in an American badger (Taxidea taxus). | Journal of zoo and wildlife medicine : official publication of the American Association of Zoo Veterinarians 20050901 |
| Differential distribution of functional alph}1-adrenergic receptor subtypes along the rat tail artery. | The Journal of pharmacology and experimental therapeutics 20050801 |
| Hybrid triple quadrupole-linear ion trap mass spectrometry in fragmentation mechanism studies: application to structure elucidation of buspirone and one of its metabolites. | Journal of mass spectrometry : JMS 20050801 |
| Postnatal treatment with NAN-190 but not with 5-HT1A receptor agonists retards growth of the rat brain. | International journal of developmental neuroscience : the official journal of the International Society for Developmental Neuroscience 20050801 |
| In vitro profile of the antidepressant candidate OPC-14523 at rat and human 5-HT1A receptors. | European journal of pharmacology 20050711 |
| Influence of inflammatory nociception on the anxiolytic-like effect of diazepam and buspirone in rats. | Psychopharmacology 20050701 |
| Pharmacological validation of a mouse model of l-DOPA-induced dyskinesia. | Experimental neurology 20050701 |
| Involvement of central serotonergic systems in dextromethorphan-induced behavioural syndrome in rats. | Indian journal of experimental biology 20050701 |
| Efficacy of buspirone in the treatment of opioid withdrawal. | Journal of clinical psychopharmacology 20050601 |
| Anxiolytic suppression of repetitive transcranial magnetic stimulation-induced anxiety in the rats. | Progress in neuro-psychopharmacology & biological psychiatry 20050601 |
| Temperament and character inventory and pharmacotherapeutic outcome in bulimia nervosa. | Eating and weight disorders : EWD 20050601 |
| Respiratory abnormalities resulting from midcervical spinal cord injury and their reversal by serotonin 1A agonists in conscious rats. | The Journal of neuroscience : the official journal of the Society for Neuroscience 20050504 |
| Oral buspirone causes a shift in the dose-response curve between the elevated-plus maze and Vogel conflict tests in Long-Evans rats: relation of brain levels of buspirone and 1-PP to anxiolytic action. | Methods and findings in experimental and clinical pharmacology 20050501 |
| Cytochrome P450 3A-mediated metabolism of buspirone in human liver microsomes. | Drug metabolism and disposition: the biological fate of chemicals 20050401 |
| Altered neuroendocrine response and gastric dysmotility in the Flinders Sensitive Line rat. | Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society 20050401 |
| Inhibitory effects of the 5-HT(1A) receptor agonist buspirone on stress-induced hyperglycemia in mice: involvement of insulin and a buspirone metabolite, 1-(2-pyrimidinyl)piperazine (1-PP). | Biological & pharmaceutical bulletin 20050401 |
| The naturally occurring Arg219Leu variant of the human 5-HT1A receptor: impairment of signal transduction. | Pharmacogenetics and genomics 20050401 |
| Effect of lactic acid and iontophoresis on drug permeation across rabbit ear skin. | International journal of pharmaceutics 20050323 |
| The effects of fluoxetine and buspirone on self-injurious and stereotypic behavior in adult male rhesus macaques. | Comparative medicine 20050201 |
| Effect of the postsynaptic 5-HT1A receptor antagonist MM-77 on stressed mice treated with 5-HT1A receptor agents. | European journal of pharmacology 20050131 |
| Incidence of sexual side effects in refractory depression during treatment with citalopram or paroxetine. | The Journal of clinical psychiatry 20050101 |
| Substance use disorder comorbidity in major depressive disorder: an exploratory analysis of the Sequenced Treatment Alternatives to Relieve Depression cohort. | Comprehensive psychiatry 20050101 |
| Buccal permeation of buspirone: mechanistic studies on transport pathways. | Journal of pharmaceutical sciences 20050101 |
| Tardive dyskinesia predicts prolactin response to buspirone challenge in people with schizophrenia. | The Journal of neuropsychiatry and clinical neurosciences 20050101 |
| Treatment of cerebellar ataxia with 5-HT1A agonist. | Cerebellum (London, England) 20050101 |
| Switching patients from olanzapine or risperidone to a combination treatment using perphenazine plus buspirone: evaluation of antipsychotic efficacy and side-effects, including extrapyramidal effects and weight loss. | Nordic journal of psychiatry 20050101 |
| The role of buspirone for the treatment of cerebellar ataxia in an older individual. | The Canadian journal of clinical pharmacology = Journal canadien de pharmacologie clinique 20050101 |
| Potentiation strategies for treatment-resistant depression. | Acta psychiatrica Scandinavica. Supplementum 20050101 |
| Comorbid anxiety and depression. | The Journal of clinical psychiatry 20050101 |
| Buspirone to improve compliance in venlafaxine-induced movement disorder. | The international journal of neuropsychopharmacology 20041201 |
| Somatodendritic and postsynaptic serotonin-1A receptors in the attenuation of haloperidol-induced catalepsy. | Progress in neuro-psychopharmacology & biological psychiatry 20041201 |
| Generalised anxiety disorder. | Clinical evidence 20041201 |
| Rapid high-performance liquid chromatographic measurement of buspirone in human plasma after overdose. | Biomedical chromatography : BMC 20041101 |
| Interactions between anxiety, social support, health status and buspirone efficacy in elderly patients. | Progress in neuro-psychopharmacology & biological psychiatry 20041101 |
| Magnesium sulfate increases the rate of hypothermia via surface cooling and improves comfort. | Stroke 20041001 |
| Anxiolytic effect of berberine on exploratory activity of the mouse in two experimental anxiety models: interaction with drugs acting at 5-HT receptors. | Life sciences 20041001 |
| Psychosocial conditions and the efficacy of clinically available anxiolytics. | Current drug targets 20041001 |
| Effects of injection of serotonin into nucleus caudatus on food and water intake and body weight in albino rats. | Indian journal of physiology and pharmacology 20041001 |
| Simple high-performance liquid chromatographic determination of buspirone in human plasma. | Farmaco (Societa chimica italiana : 1989) 20040901 |
| Paroxetine in the treatment of generalised anxiety disorder. | Expert opinion on pharmacotherapy 20040801 |
| Cooling for Acute Ischemic Brain Damage (COOL AID): a feasibility trial of endovascular cooling. | Neurology 20040727 |
| Social instability in female rats: effects on anxiety and buspirone efficacy. | Psychopharmacology 20040701 |
| Effect of the 5HT1A receptor partial agonist buspirone on colorectal distension-induced pseudoaffective and behavioral responses in the female Wistar rat. | European journal of pharmacology 20040621 |
| Exposure to an elevated platform increases plasma corticosterone and hippocampal acetylcholine in the rat: reversal by chlordiazepoxide. | European journal of pharmacology 20040616 |
| Intrinsic activity and comparative molecular dynamics of buspirone analogues at the 5-HT(1A) receptors. | Biochemical pharmacology 20040615 |
| Buspirone raises blood pressure through activation of sympathetic nervous system and by direct activation of alpha1-adrenergic receptors after severe hemorrhage. | The Journal of pharmacology and experimental therapeutics 20040601 |
| Buspirone challenge is not a valid probe of central 5-HT1A receptor function. | Cephalalgia : an international journal of headache 20040601 |
| Prediction of the affinity of the newly synthesised azapirone derivatives for 5-HT1A receptors based on artificial neural network analysis of chromatographic retention data and calculation chemistry parameters. | Combinatorial chemistry & high throughput screening 20040601 |
| Genotype-dependent changes in pain thresholds in adult mice after neonatal treatment. | Bulletin of experimental biology and medicine 20040601 |
| Generalised anxiety disorder. | Clinical evidence 20040601 |
| Effect of environmental enrichment on stress related systems in rats. | Journal of neuroendocrinology 20040501 |
| [Combination of serotonergic agents resulted in severe adverse effects]. | Lakartidningen 20040429 |
| Effects of acute and chronic buspirone on impulsive choice and efflux of 5-HT and dopamine in hippocampus, nucleus accumbens and prefrontal cortex. | Psychopharmacology 20040401 |
| The photocatalytic process as a tool to identify metabolitic products formed from dopant substances: the case of buspirone. | Journal of pharmaceutical and biomedical analysis 20040401 |
| Development and validation of a high-performance liquid chromatographic method for the determination of buspirone in pharmaceutical preparations. | Journal of pharmaceutical and biomedical analysis 20040401 |
| New imide 5-HT1A receptor ligands - modification of terminal fragment geometry. | Molecules (Basel, Switzerland) 20040227 |
| Adsorptive stripping voltammetric behaviour of azomethine group in pyrimidine-containing drugs. | Journal of pharmaceutical and biomedical analysis 20040218 |
| Systemic absorption of amitriptyline and buspirone after oral and transdermal administration to healthy cats. | Journal of veterinary internal medicine 20040101 |
| A randomized, placebo-controlled trial of buspirone for the treatment of anxiety in opioid-dependent individuals. | The American journal on addictions 20040101 |
| Effects of buspirone and alprazolam treatment on the startle-potentiated startle response. | Depression and anxiety 20040101 |
| Cortisol response to buspirone in extended abstinent alcoholics. | Alcohol and alcoholism (Oxford, Oxfordshire) 20040101 |
| Neonatal administration of buspiron causes changes in intermale aggression of adult mice. | Doklady biological sciences : proceedings of the Academy of Sciences of the USSR, Biological sciences sections 20040101 |
| 1-(2-pyrimidinyl)-piperazine, a buspirone metabolite, modulates bladder function in the anesthetized rat. | Neurourology and urodynamics 20040101 |
| Selecting pharmacotherapy for generalized anxiety disorder. | The Journal of clinical psychiatry 20040101 |
| Effect of the novel anxiolytic drug deramciclane on the pharmacokinetics and pharmacodynamics of the CYP3A4 probe drug buspirone. | European journal of clinical pharmacology 20031201 |
| Sensitization of adenylate cyclase by short-term activation of 5-HT1A receptors. | Cellular signalling 20031201 |
| The serotonergic system may be involved in the sleep-inducing action of oleamide in rats. | Naunyn-Schmiedeberg's archives of pharmacology 20031201 |
| The effect of social factors on the anxiolytic efficacy of buspirone in male rats, male mice, and men. | Progress in neuro-psychopharmacology & biological psychiatry 20031201 |
| Effects of the serotonergic anxiolytic buspirone on plasma glucose and glucose-induced hyperglycemia in mice. | Journal of pharmacological sciences 20031201 |
| Anxiolytic effects of the novel anti-epileptic drug levetiracetam in the elevated plus-maze test in the rat. | European journal of pharmacology 20031114 |
| Buspirone for anxiety and agitation in dementia. | Journal of psychiatry & neuroscience : JPN 20031101 |
| Enhanced iontophoretic delivery of buspirone hydrochloride across human skin using chemical enhancers. | International journal of pharmaceutics 20031002 |
| Harm avoidance, anxiety, and response to novelty in the adolescent S-100beta transgenic mouse: role of serotonin and relevance to Down syndrome. | Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20031001 |
| Imipramine and buspirone in patients with panic disorder who are discontinuing long-term benzodiazepine therapy. | Journal of clinical psychopharmacology 20031001 |
| Buspirone treatment for apneustic breathing in brain stem infarct. | Respiratory care 20031001 |
| Effect of anxiolytic drugs on air-puff-elicited ultrasonic vocalization in adult rats. | Experimental animals 20031001 |
| Buspirone differentially modifies short-term memory function in a combined delayed matching/non-matching to position task. | European journal of pharmacology 20030923 |
| Faster response in depressive patients treated with fluoxetine alone than in combination with buspirone. | Journal of affective disorders 20030901 |
| The safety of SSRIs in generalised anxiety disorder: any reason to be anxious? | Expert opinion on drug safety 20030901 |
| Pharmacokinetic evaluation of gepirone immediate-release capsules and gepirone extended-release tablets in healthy volunteers. | Journal of pharmaceutical sciences 20030901 |
| Stress, social avoidance and anxiolytics: a potential model of stress-induced anxiety. | Behavioural pharmacology 20030901 |
| Effects of highly or relatively selective 5-HT1A receptor agonists on lordosis in female rats. | Zoological science 20030901 |
| Methylphenidate-induced obsessive-compulsive symptoms in an elderly man. | CNS spectrums 20030801 |
| An open trial of buspirone in the treatment of attention-deficit disorder. | Human psychopharmacology 20030801 |
| A quantitative method for assessing of the affective component of the pain: conditioned response associated with CO2 laser-induced nocifensive reaction. | Brain research. Brain research protocols 20030801 |
| The phenomenon of one-trial tolerance to the anxiolytic effect of chlordiazepoxide in the elevated plus-maze test is abolished by previous administration of chlordiazepoxide or buspirone. | Life sciences 20030711 |
| Effects of autoshaping procedures on 3H-8-OH-DPAT-labeled 5-HT1a binding and 125I-LSD-labeled 5-HT2a binding in rat brain. | Brain research 20030613 |
| A 5-HT1A agonist and a 5-HT2c antagonist reduce social interaction deficit induced by multiple ethanol withdrawals in rats. | Psychopharmacology 20030601 |
| Responses to exercise in the heat related to measures of hypothalamic serotonergic and dopaminergic function. | European journal of applied physiology 20030601 |
| Altered dopamine D2 receptor function in fibromyalgia patients: a neuroendocrine study with buspirone in women with fibromyalgia compared to female population based controls. | Journal of affective disorders 20030601 |
| Iontophoretic transdermal delivery of buspirone hydrochloride in hairless mouse skin. | AAPS pharmSci 20030601 |
| Generalised anxiety disorder. | Clinical evidence 20030601 |
| Serotonin 1A receptor agonists reverse respiratory abnormalities in spinal cord-injured rats. | The Journal of neuroscience : the official journal of the Society for Neuroscience 20030515 |
| 8-[3H]-hydroxy-2-(di-n-propylamino)tetralin binding sites in blood lymphocytes of rats and the modulation by mitogens and immobilization. | Journal of neuroimmunology 20030501 |
| Effects of venlafaxine, buspirone, and placebo on colonic sensorimotor functions in healthy humans. | Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 20030501 |
| 22-kHz ultrasonic vocalization in rats as an index of anxiety but not fear: behavioral and pharmacological modulation of affective state. | Behavioural brain research 20030417 |
| Buspirone-induced antinociception is mediated by L-type calcium channels and calcium/caffeine-sensitive pools in mice. | Psychopharmacology 20030301 |
| EEG effects of buspirone and pindolol: a method of examining 5-HT1A receptor function in humans. | Psychopharmacology 20030301 |
| Human cytochromes mediating gepirone biotransformation at low substrate concentrations. | Biopharmaceutics & drug disposition 20030301 |
| Effects of chronic treatment with ipsapirone and buspirone on the C57BL/6J strain mice under social stress. | Life sciences 20030214 |
| Development and validation of an in vitro-in vivo correlation for buspirone hydrochloride extended release tablets. | Journal of controlled release : official journal of the Controlled Release Society 20030214 |
| Central 5-HT receptor hypersensitivity in migraine without aura. | Cephalalgia : an international journal of headache 20030201 |
| 5-HT1A receptor activity disrupts spontaneous alternation behavior in rats. | Pharmacology, biochemistry, and behavior 20030201 |
| Venlafaxine-induced galactorrhea. | Journal of clinical psychopharmacology 20030201 |
| Pseudo-Parkinson disease secondary to ritonavir-buspirone interaction. | The Annals of pharmacotherapy 20030201 |
| Effect of the serotonin agonist buspirone on behaviour and hypothalamic-pituitary-adrenal axis in confident and fearful mink. | Physiology & behavior 20030201 |
| Differing central amine receptor sensitivity in different migraine subtypes? A neuroendocrine study using buspirone. | Pain 20030201 |
| Development of a presynaptic 5-HT1A antagonist. | Bioorganic & medicinal chemistry letters 20030120 |
| In vivo comparison of two 5-HT1A receptors agonists alnespirone (S-20499) and buspirone on locus coeruleus neuronal activity. | European journal of pharmacology 20030110 |
| Buspirone decreases physiological reactivity to unconditioned and conditioned aversive stimuli. | Psychopharmacology 20030101 |
| Effects of cholecystokinin tetrapeptide (CCK(4)) and of anxiolytic drugs on GABA outflow from the cerebral cortex of freely moving rats. | Neurochemistry international 20030101 |
| Selective effects of serotonergic psychoactive agents on gastrointestinal functions in health. | American journal of physiology. Gastrointestinal and liver physiology 20030101 |
| Treating generalized anxiety disorder. | The Journal of clinical psychiatry 20030101 |
| Kava-Kava extract LI 150 is as effective as Opipramol and Buspirone in Generalised Anxiety Disorder--an 8-week randomized, double-blind multi-centre clinical trial in 129 out-patients. | Phytomedicine : international journal of phytotherapy and phytopharmacology 20030101 |
| Effects of buspirone in withdrawal from opiates. | The American journal on addictions 20030101 |
| Electrospray mass spectrometric studies of noncovalent complexes of buspirone hydrochloride and other serotonin 5-HT(1A) receptor ligands containing arylpiperazine moieties. | Rapid communications in mass spectrometry : RCM 20030101 |
| [Effect of buspirone on aggressive and anxiety behavior of male mice with various aggressive experience]. | Eksperimental'naia i klinicheskaia farmakologiia 20030101 |
| Effects of ethanol and 5-HT1A agonists on astroglial S100B. | Brain research. Developmental brain research 20021215 |
| Pharmacokinetic-pharmacodynamic modeling of buspirone and its metabolite 1-(2-pyrimidinyl)-piperazine in rats. | The Journal of pharmacology and experimental therapeutics 20021201 |
| Treatment of generalised anxiety disorder with a short course of psychological therapy, combined with buspirone or placebo. | Journal of affective disorders 20021201 |
| Indorenate produces antidepressant-like actions in the rat forced swimming test via 5-HT1A receptors. | Psychopharmacology 20021201 |
| Treatment functional GI disease: the complex pharmacology of serotonergic drugs. | British journal of clinical pharmacology 20021201 |
| Possible serotonin syndrome after combination of buspirone and St John's Wort. | Journal of psychopharmacology (Oxford, England) 20021201 |
| Cocaine-induced anxiety: alleviation by diazepam, but not buspirone, dimenhydrinate or diphenhydramine. | Behavioural pharmacology 20021101 |
| Modulation of reflexly evoked vagal bradycardias by central 5-HT1A receptors in anaesthetized rabbits. | British journal of pharmacology 20021101 |
| Rigid analogues of buspirone and gepirone, 5-HT1A receptors partial agonists. | Farmaco (Societa chimica italiana : 1989) 20021101 |
| Effects of triazolam, 8-OH-DPAT, and buspirone on repeated acquisition in squirrel monkeys. | Experimental and clinical psychopharmacology 20021101 |
| Developing strategies for isolation of minor impurities with mass spectrometry-directed fractionation. | Journal of chromatography. A 20020913 |
| Anxiolytic-like activity of the mGluR5 antagonist MPEP: a comparison with diazepam and buspirone. | Pharmacology, biochemistry, and behavior 20020901 |
| The effects of alprazolam and buspirone in light and moderate female social drinkers. | Behavioural pharmacology 20020901 |
| Serotonin 1A receptor activation and hypothermia in humans: lack of evidence for a presynaptic mediation. | Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 20020801 |
| A preliminary study of buspirone stimulated prolactin release in generalised social phobia: evidence for enhanced serotonergic responsivity? | European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 20020801 |
| Clinical inquiries. What are the treatment options for SSRI-related sexual dysfunction? | The Journal of family practice 20020801 |
| Postsynaptic 5-HT(1A) receptors mediate an increase in locomotor activity in the monoamine-depleted rat. | Psychopharmacology 20020801 |
| [Buspirone chlorhydrate in the treatment of cerebellar ataxia]. | Revista de neurologia 20020801 |
| [Preparation of buspirone hydrochloride buccal adhesive tablet and study on its drug release mechanism]. | Yao xue xue bao = Acta pharmaceutica Sinica 20020801 |
| Influence of forced swimming-induced stress on the anxiolytic-like effect of 5HT(1A) agents in mice. | Psychopharmacology 20020701 |
| The use of buspirone in primary care. | Journal of psychosocial nursing and mental health services 20020701 |
| Withdrawal from chronic ethanol increases the sensitivity of presynaptic 5-HT(1A) receptors modulating serotonin and dopamine synthesis in rat brain in vivo. | Neuroscience letters 20020628 |
| Region-dependent effects of flibanserin and buspirone on adenylyl cyclase activity in the human brain. | The international journal of neuropsychopharmacology 20020601 |
| Extended action of MKC-242, a selective 5-HT(1A) receptor agonist, on light-induced Per gene expression in the suprachiasmatic nucleus in mice. | Journal of neuroscience research 20020515 |
| Tandospirone potentiates the fluoxetine-induced increases in extracellular dopamine via 5-HT(1A) receptors in the rat medial frontal cortex. | Neurochemistry international 20020401 |
| Hypomania induced by herbal and pharmaceutical psychotropic medicines following mild traumatic brain injury. | Brain injury 20020401 |
| Contact leukoderma caused by buspirone patches. | American journal of contact dermatitis : official journal of the American Contact Dermatitis Society 20020301 |
| [Buspirone increases D2-like dopaminergic receptor density in rat corpus striatum]. | Arquivos de neuro-psiquiatria 20020301 |
| Benzodiazepine discontinuation in generalized anxiety disorder. | The American journal of psychiatry 20020201 |
| Acute buspirone abolishes the expression of behavioral dopaminergic supersensitivity in mice. | Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas 20020201 |
| Bupropion-induced acute dystonia. | The Annals of pharmacotherapy 20020201 |
| Olfactory-mediated fear-potentiated startle. | Behavioral neuroscience 20020201 |
| Pharmacological and endocrinological characterisation of stress-induced hyperthermia in singly housed mice using classical and candidate anxiolytics (LY314582, MPEP and NKP608). | European journal of pharmacology 20020125 |
| Short term aerobic exercise training in young males does not alter sensitivity to a central serotonin agonist. | Experimental physiology 20020101 |
| Seed finding in golden hamsters: a potential animal model for screening anxiolytic drugs. | Neuropsychobiology 20020101 |
| Treatment of generalized anxiety disorder. | The Journal of clinical psychiatry 20020101 |
| Marked suppression of gastric ulcerogenesis and intestinal responses to stress by a novel class of drugs. | Molecular psychiatry 20020101 |
| Generalised anxiety disorder: treatment options. | Drugs 20020101 |
| Pharmacotherapy of generalized anxiety disorder. | The Journal of clinical psychiatry 20020101 |
| 13C cpmas nmr and molecular modeling in the studies of new analogues of buspirone. | Acta poloniae pharmaceutica 20020101 |
| Effects of cholecystokinin tetrapeptide (CCK(4)) and anxiolytic drugs on the electrically evoked [(3)H]5-hydroxytryptamine outflow from rat cortical slices. | Brain research 20011213 |
| Pharmacokinetics and tolerability of buspirone during oral administration to children and adolescents with anxiety disorder and normal healthy adults. | Journal of clinical pharmacology 20011201 |
| Astrocyte-mediated trophic support of developing serotonin neurons: effects of ethanol, buspirone, and S100B. | Brain research. Developmental brain research 20011126 |
| Buspirone and meperidine synergistically reduce the shivering threshold. | Anesthesia and analgesia 20011101 |
| Quantifying the 5-HT1A agonist action of buspirone in man. | Psychopharmacology 20011101 |
| Acoustic startle, conditioned startle potentiation and the effects of 8-OH-DPAT and buspirone in rats selectively bred for differences in 8-OH-DPAT-induced hypothermia. | Behavioural pharmacology 20011101 |
| Pattern of symptom improvement following treatment with venlafaxine XR in patients with generalized anxiety disorder. | The Journal of clinical psychiatry 20011101 |
| Molecular dynamics of 5-HT1A and 5-HT2A serotonin receptors with methylated buspirone analogues. | Journal of computer-aided molecular design 20011101 |
| Impact of cortisol on buspirone stimulated prolactin release: a double-blind placebo-controlled study. | Psychoneuroendocrinology 20011001 |
| Small platform stress increases exploratory activity of mice in staircase test. | Progress in neuro-psychopharmacology & biological psychiatry 20011001 |
| A double-blind placebo-controlled study of buspirone-stimulated prolactin release in non-ulcer dyspepsia--are central serotoninergic responses enhanced? | Alimentary pharmacology & therapeutics 20011001 |
| The effect of glucocorticoids on the anxiolytic efficacy of buspirone. | Psychopharmacology 20011001 |
| Diazepam, but not buspirone, induces similar anxiolytic-like actions in lactating and ovariectomized Wistar rats. | Pharmacology, biochemistry, and behavior 20010901 |
| Effectiveness of pharmacotherapy for body dysmorphic disorder: a chart-review study. | The Journal of clinical psychiatry 20010901 |
| An open study of buspirone augmentation of neuroleptics in patients with schizophrenia. | Journal of clinical psychopharmacology 20010801 |
| Ataxia from lithium toxicity successfully treated with high-dose buspirone: a single-case experimental design. | Archives of physical medicine and rehabilitation 20010801 |
| A comparative multidose pharmacokinetic study of buspirone extended-release tablets with a reference immediate-release product. | Journal of clinical pharmacology 20010801 |
| Switching from benzodiazepines to buspirone using a tapered overlap method in generalized anxiety disorder. | The Journal of clinical psychiatry 20010801 |
| [Permeation of buspirone hydrochloride across animal buccal mucosa and its mechanism]. | Yao xue xue bao = Acta pharmaceutica Sinica 20010801 |
| Characterization of alpha1-adrenoceptor-mediated contraction in the mouse thoracic aorta. | European journal of pharmacology 20010720 |
| Serotonin-based pharmacotherapy for acute neuroleptic-induced akathisia: a new approach to an old problem. | The British journal of psychiatry : the journal of mental science 20010701 |
| Late-onset bipolar disorder due to hyperthyroidism. | Acta psychiatrica Scandinavica 20010701 |
| Common effects of chronically administered antipanic drugs on brainstem GABA(A) receptor subunit gene expression. | Molecular psychiatry 20010701 |
| Pharmacokinetics of buspirone extended-release tablets: a single-dose study. | Journal of clinical pharmacology 20010701 |
| An open trial of divalproex sodium in autism spectrum disorders. | The Journal of clinical psychiatry 20010701 |
| Potential involvement of S100B in the protective effects of a serotonin-1a agonist on ethanol-treated astrocytes. | Brain research. Developmental brain research 20010629 |
| SSRI discontinuation and buspirone. | The American journal of psychiatry 20010601 |
| Patients with severe depression may benefit from buspirone augmentation of selective serotonin reuptake inhibitors: results from a placebo-controlled, randomized, double-blind, placebo wash-in study. | The Journal of clinical psychiatry 20010601 |
| An investigation of the mechanisms responsible for acute fluoxetine-induced anxiogenic-like effects in mice. | Behavioural pharmacology 20010601 |
| 5-HT1A receptor activation and antidepressant-like effects: F 13714 has high efficacy and marked antidepressant potential. | European journal of pharmacology 20010525 |
| Biochemical, electrophysiological and neurohormonal studies with B-20991, a selective 5-HT1A receptor agonist. | Pharmacology 20010501 |
| Quantifying drug-related 5-HT1A receptor occupancy with. | Psychopharmacology 20010501 |
| Compounds with affinity for serotonergic receptors in the treatment of premenstrual dysphoria: a comparison of buspirone, nefazodone and placebo. | Psychopharmacology 20010501 |
| Does pretreatment anxiety predict response to either bupropion SR or sertraline? | Journal of affective disorders 20010401 |
| Molecular dynamics of buspirone analogues interacting with the 5-HT1A and 5-HT2A serotonin receptors. | Bioorganic & medicinal chemistry 20010401 |
| Effect of anxiolytics on blood sugar level in rabbits. | Indian journal of experimental biology 20010401 |
| Ligand induced conformational states of the 5-HT(1A) receptor. | European journal of pharmacology 20010323 |
| Population pharmacokinetic-pharmacodynamic modelling of S 15535, a 5-HT(1A) receptor agonist, using a behavioural model in rats. | European journal of pharmacology 20010302 |
| Is imipramine or buspirone treatment effective in patients wishing to discontinue long-term benzodiazepine use? | The Journal of family practice 20010301 |
| Female sexual dysfunction and antidepressant use. | The American journal of psychiatry 20010201 |
| Citalopram-induced bruxism. | The British journal of psychiatry : the journal of mental science 20010201 |
| Prenatal stress and postnatal development of neonatal rats--sex-dependent effects on emotional behavior and learning ability of neonatal rats. | International journal of developmental neuroscience : the official journal of the International Society for Developmental Neuroscience 20010201 |
| Behavioral effects of buspirone in the marmoset employing a predator confrontation test of fear and anxiety. | Pharmacology, biochemistry, and behavior 20010201 |
| Serotonin syndrome. A common but often unrecognized psychiatric condition. | Geriatrics 20010101 |
| Recovery from chronic fatigue syndrome associated with changes in neuroendocrine function. | Journal of the Royal Society of Medicine 20010101 |
| Strategies for the treatment of antidepressant-related sexual dysfunction. | The Journal of clinical psychiatry 20010101 |
| New developments in the pharmacotherapy of alcohol dependence. | The American journal on addictions 20010101 |
| Use of negatively reinforcing electrical brain stimulation to detect conventional and nonconventional anxiolytics as well as an anxiogenic drug. | Pharmacology, biochemistry, and behavior 20010101 |
| Pharmacotherapy of generalized anxiety disorder. | The Journal of clinical psychiatry 20010101 |
| Neuropharmacological analysis of the role of the serotoninergic system in forming hyperalgesia in neurotic rats. | Neuroscience and behavioral physiology 20010101 |
| Contemporary management of comorbid anxiety and depression in geriatric patients. | The Journal of clinical psychiatry 20010101 |
| Behavioral and biochemical effects of L-tryptophan and buspirone in a model of cerebellar atrophy. | Pharmacology, biochemistry, and behavior 20010101 |
| Overview of different pharmacotherapies for attaining remission in generalized anxiety disorder. | The Journal of clinical psychiatry 20010101 |
| Effect of citalopram and buspirone on the antinociceptive action of analgesic drugs. | Acta poloniae pharmaceutica 20010101 |
| [The role of neuropeptide Y in anxiety]. | Psychiatria polska 20010101 |
| Estimation of buspirone-bovine serum albumin binding by affinity capillary electrophoresis. | Acta poloniae pharmaceutica 20010101 |
| 5-HT1A receptor agonists buspirone and gepirone attenuate apomorphine-induced aggressive behaviour in adult male Wistar rats. | Journal of physiology and pharmacology : an official journal of the Polish Physiological Society 20001201 |
| Effects of serotoninergic drugs on tremor induced by physostigmine in rats. | Behavioural brain research 20000501 |
| Reversal of morphine-induced apnea in the anesthetized rat by drugs that activate 5-hydroxytryptamine(1A) receptors. | The Journal of pharmacology and experimental therapeutics 20000201 |
| Female sexual dysfunction associated with antidepressant administration: a randomized, placebo-controlled study of pharmacologic intervention. | The American journal of psychiatry 20000201 |
| Possible serotonin syndrome associated with buspirone added to fluoxetine. | The Annals of pharmacotherapy 20000101 |
| Effect of buspirone on sexual dysfunction in depressed patients treated with selective serotonin reuptake inhibitors. | Journal of clinical psychopharmacology 19990601 |
| Apomorphine-induced aggressiveness and [3H]citalopram binding after antidepressant treatment in rats. | Pharmacology, biochemistry, and behavior 19980301 |
| Seizures associated with buspirone overdose: case report and literature review. | Clinical neuropharmacology 19980101 |
| The putative 5-HT1A receptor antagonist DU125530 blocks the discriminative stimulus of the 5-HT1A receptor agonist flesinoxan in pigeons. | European journal of pharmacology 19970501 |
| Combined serotonin syndrome and hyponatraemia caused by a citalopram-buspirone interaction. | International clinical psychopharmacology 19970101 |
| The effect of buspirone on challenging behaviour in mentally retarded patients: an open prospective multiple-case study. | Journal of intellectual disability research : JIDR 19961201 |
| Efficacy of buspirone in generalized anxiety disorder with coexisting mild depressive symptoms. | The Journal of clinical psychiatry 19960701 |
| Structure activity relationships of a series of buspirone analogs at alpha-1 adrenoceptors: further evidence that rat aorta alpha-1 adrenoceptors are of the alpha-1D-subtype. | The Journal of pharmacology and experimental therapeutics 19960701 |
| Psychiatric illness and the serotonin syndrome: an emerging adverse drug effect leading to intensive care unit admission. | Critical care medicine 19960601 |
| Disappearance of psychosis after buspirone treatment. | The American journal of psychiatry 19960201 |
| [Efficacy and withdrawal of clobazam, lorazepam and buspirone in the treatment of anxiety disorders]. | L'Encephale 19960101 |
| Buspirone, but not sumatriptan, induces miosis in humans: relevance for a serotoninergic pupil control. | Clinical pharmacology and therapeutics 19950301 |
| Buspirone in levodopa-induced dyskinesias. | Clinical neuropharmacology 19940201 |
| Persistent movement disorders induced by buspirone. | Movement disorders : official journal of the Movement Disorder Society 19930701 |
| A double-blind study of adjuvant buspirone hydrochloride in clomipramine-treated patients with obsessive-compulsive disorder. | Journal of clinical psychopharmacology 19920201 |
| Seizure associated with fluoxetine and adjuvant buspirone therapy. | Journal of clinical psychopharmacology 19920201 |
| Low but not high doses of buspirone reduce the anxiogenic effects of diazepam withdrawal. | Psychopharmacology 19910101 |
| Buspirone-induced mania. | The British journal of psychiatry : the journal of mental science 19910101 |
| Persistent dystonia associated with buspirone. | Neurology 19901201 |
| Paradoxical reaction to buspirone augmentation of fluoxetine. | Journal of clinical psychopharmacology 19901001 |
| [Acute toxicity study of buspirone hydrochloride in mice, rats and dogs]. | The Journal of toxicological sciences 19900401 |
| Possible induction of mania by buspirone. | The American journal of psychiatry 19900101 |
| Panic and hypertension associated with single dose of buspirone. | Lancet (London, England) 19890701 |
| Adjunctive buspirone in benzodiazepine treatment of four patients with panic disorder. | The American journal of psychiatry 19890701 |
| Buspirone-induced mania. | Journal of clinical psychopharmacology 19890401 |
| Effects of 5-HT1A agonists and 5-HT2 antagonists on haloperidol-induced dyskinesias in squirrel monkeys: no evidence for reciprocal 5-HT-dopamine interaction. | Psychopharmacology 19890101 |
| Strychnine seizure potentiation by azaspirodecanedione anxiolytics in rats. | European journal of pharmacology 19881018 |
| Acute generalized myoclonus following buspirone administration. | The Journal of clinical psychiatry 19880601 |
| Buspirone-induced hypomania: a case report. | Journal of clinical psychopharmacology 19880601 |
| Combined effects of buspirone and diazepam on objective and subjective tests of performance in healthy volunteers. | Clinical pharmacology and therapeutics 19861201 |
| Review of the side-effect profile of buspirone. | The American journal of medicine 19860331 |
| The side effect profile of buspirone in comparison to active controls and placebo. | The Journal of clinical psychiatry 19821201 |
Related Products
Featured Products
© 2019 Angene International Limited. All rights Reserved.